HPV infection
Conditions
Interventions
Experimental Group:The cervix was treated with local application of Petaline
Sponsors
The Second Affiliated Hospital of Zhejiang University School of Medicine
Eligibility
Sex/Gender
Female
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Aged 21 to 65, with a history of sexual life; 2. The HR-HPV test is positive and has persisted for 6 months or more; 3. Those diagnosed with low-grade cervical intraepithelial lesions or below through colposcopy pathology; 4. No underlying diseases of vital organs; 5. Those who agree to receive treatment and/or follow-up as prescribed and sign the informed consent form; 6. There has been no history of using other cervical drugs in the past three months.
Exclusion criteria
Exclusion criteria: 1.Non-persistent HR-HPV infection; 2. Low immune function or immune system diseases, such as systemic lupus erythematosus (SLE), etc. 3. Currently using immunosuppressants, glucocorticoids and other drugs; 4. Pregnant and lactating women; 5. Acute reproductive tract inflammation; 6. Patients with uncontrolled blood sugar levels due to diabetes; 7. Patients who do not receive full treatment and follow-up; 8. Those who fail to sign the informed consent form; 9. If the researcher assesses and determines that there are any unstable conditions that may affect patient safety and compliance or lead to the forced termination of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HPV infection rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Low grade cervical intraepithelial lesion; | — |
Countries
China
Contacts
Public ContactXuejun Chen
The Second Affiliated Hospital of Zhejiang University School of Medicine
Outcome results
None listed